Track: Cardiac Arrhythmias

Heart 2023 Conference - Cardiac Arrhythmias


The market for arrhythmias was estimated to be worth USD 6.39 billion in 2021 and is anticipated to expand at a CAGR of 6.8% during the next five years. Increased incidences of unhealthy lifestyle choices including smoking, binge drinking, and obesity (which make a person more susceptible to cardiac arrhythmias) as well as rising patient awareness levels are driving the industry's growth. According to a survey by Acumen Research and Consulting, the global market for cardiac arrhythmia monitoring devices, which was valued at USD 6,485 million in 2021, is anticipated to grow to USD 11,490 million by 2030, with a sizable CAGR of 6.8% from 2022 to 2030.


·        Arrhythmias, General – Treatment
·        Atrial Fibrillation
·        Atrial Fibrillation - Epidemiology, Prognosis, Outcome
·        Atrial Fibrillation - Treatment
·        Atrial Fibrillation - Stroke Prevention
·        Supraventricular Tachycardia (non-AF)
·        Supraventricular Tachycardia (non-AF) - Pathophysiology and Mechanisms
·        Supraventricular Tachycardia (non-AF) - Epidemiology, Prognosis, Outcome
·        Supraventricular Tachycardia (non-AF) - Diagnostic Methods
·        Supraventricular Tachycardia (non-AF) - Treatment
·        Supraventricular Tachycardia (non-AF) - Prevention
·        Supraventricular Tachycardia (non-AF) - Clinical
·        Syncope and Bradycardia
·        Syncope and Bradycardia - Pathophysiology and Mechanisms
·        Bradycardia - AV-Block
·        Tachycardia
·        Non-arrhythmogenic Mechanisms of Syncope
·        Syncope and Bradycardia - Epidemiology, Prognosis, Outcome
·        Syncope and Bradycardia - Diagnostic Methods
·        Syncope and Bradycardia - Treatment
·        Drug Treatment
·        Pacemaker Therapy
·        Syncope and Bradycardia - Clinical
·        Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
·        Ventricular Arrhythmias and SCD - Epidemiology, Prognosis, Outcome
·        Ventricular Arrhythmias and SCD - Treatment
·        Management of Out of Hospital Cardiac Arrest
·        Device Treatment of Ventricular Arrhythmias and SCD
·        Ventricular Arrhythmias and SCD - Clinical
·        Device Therapy
·        Device Complications and Lead Extraction 

Related Hospitals: Cleveland ClinicMayo Clinic, New York-Presbyterian Hospital, Cedars-Sinai Medical CenterMassachusetts General Hospital, NewYork-Presbyterian Hospital-Columbia and Cornell, Johns Hopkins HospitalNYU Langone Hospitals, Northwestern Memorial Hospital, Hospitals of the University of Pennsylvania-Penn Presbyterian, Mount Sinai HospitalUniversity of Michigan Hospitals and Health Centers, Duke University HospitalBrigham and Women's Hospital, Barnes-Jewish Hospital, UCLA Medical Center, Stanford Health Care-Stanford Hospital, Heart Hospital Baylor Plano, Houston Methodist Hospital, Loyola University Medical Center, NYU Langone Medical Center, UPMC Presbyterian Shadyside, Scripps La Jolla Hospitals, Ohio State University Wexner Medical Center, UCSF Medical Center, Sentara Norfolk General Hospital-Sentara Heart Hospital, Texas Heart Institute at Baylor St. Luke's Medical Center, Beaumont Hospital-Royal Oak, Minneapolis Heart Institute at Abbott Northwestern Hospital, Vanderbilt University Medical Center, Memorial Hermann-Texas Medical Center, The University of Alabama at Birmingham Hospital, University of Colorado HospitalSt. Francis Hospital.